Gentamicin and Hydroxocobalamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gentamicin (gentamicin sulfate) and Hydroxocobalamin (hydroxocobalamin). Common drug interactions include neutropenic sepsis among females and hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Gentamicin and Hydroxocobalamin. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.



On Jul, 11, 2026

62 people who take Gentamicin and Hydroxocobalamin together, and have interactions are studied.

Gentamicin and Hydroxocobalamin drug interactions.

What are the common drug interactions of Gentamicin and Hydroxocobalamin, by gender? *:

female:

  1. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  2. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  3. Diarrhoea
  4. Arthralgia (joint pain)
  5. Bone pain
  6. C-reactive protein increased
  7. Mucosal inflammation (infection of mucous membrane)
  8. Oedema peripheral (superficial swelling)
  9. Vomiting
  10. Wound

male:

  1. Hypersensitivity
  2. Lip swelling
  3. Terminal state (the transitional states between life and biological death)
  4. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  5. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  6. Ill-defined disorder
  7. Prostatic abscess (a closed pocket containing pus within the prostate)
  8. Anaemia (lack of blood)
  9. Blood glucose decreased
  10. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)

What are the common drug interactions of Gentamicin and Hydroxocobalamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Blood albumin decreased
  2. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  2. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  3. Cancer pain
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Disease progression
  6. Pain in extremity
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Electrolyte imbalance
  9. Blood albumin decreased
  10. Cough

What are the existing conditions these people have? *

  1. Dry Skin: 24 people, 38.71%
  2. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 23 people, 37.10%
  3. Wound: 22 people, 35.48%
  4. Skin Ulcer: 22 people, 35.48%
  5. Breast Cancer Metastatic: 22 people, 35.48%
  6. Cellulitis (infection under the skin): 22 people, 35.48%
  7. Fever: 22 people, 35.48%
  8. Abdominal Hernia Obstructive (abdominal hernia causing a blockage): 22 people, 35.48%
  9. Joint Pain: 22 people, 35.48%
  10. Oedema Peripheral (superficial swelling): 22 people, 35.48%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin and Hydroxocobalamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gentamicin and Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gentamicin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxocobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate and hydroxocobalamin (the active ingredients of Gentamicin and Hydroxocobalamin, respectively), and Gentamicin and Hydroxocobalamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: